{"schema_version":"secwatch.filing_event.v1","accession":"0001100682-22-000002","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2022-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.417377+00:00","generated_at":"2026-06-27T18:50:30.270453+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"Charles River Labs CFO David Smith to retire; provides preliminary 2022 guidance","bullets":["CFO David R. Smith will retire; he will remain until a successor is named, expected by end of 2022.","At J.P. Morgan Healthcare Conference, management presented preliminary 2022 outlook for revenue growth, organic revenue growth, non-GAAP operating margin, non-GAAP EPS, free cash flow, and capex.","Specific numerical guidance was not included in the filing; slide deck is available on the company's IR website."],"urls":{"canonical":"https://secwatch.observer/filing/0001100682-22-000002","json":"https://secwatch.observer/filing/0001100682-22-000002.json","markdown":"https://secwatch.observer/filing/0001100682-22-000002.md","text":"https://secwatch.observer/filing/0001100682-22-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000002/0001100682-22-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000002/crl-20220111.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T18:50:30.270453+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cfeeabed5f","claim":"David R. Smith departed as Corporate Executive Vice President and Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..","evidence_excerpt":"On January 11, 2022, Charles River Laboratories International, Inc. (the “Company”) announced that David R. Smith, its Corporate Executive Vice President and Chief Financial Officer, will retire from the Company after a distinguished career in healthcare and finance leadership roles.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000002/0001100682-22-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Corporate Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}